Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Cinqair (Reslizumab).

Acute asthma attacks: Cinqair (Reslizumab) is not intended to treat an acute asthma attack.

If you start developing asthma symptoms, be sure to use your reliever medication for rapid relief of your asthma symptoms. It is very important that you have your reliever medication with you at all times. If you experience worsening symptoms or your reliever medications are not as effective as usual, contact your doctor or seek medical attention immediately.

Allergic reactions: In rare cases, some people may develop a serious allergic reaction to Cinqair (Reslizumab). Signs of an allergic reaction include a severe rash, Hives, swollen face or throat, or difficulty breathing. If these occur, let your doctor know immediately.

Corticosteroid withdrawal: Oral or inhaled corticosteroids for asthma should not be stopped suddenly when treatment with Cinqair (Reslizumab) is started. Check with your doctor before stopping or decreasing the dose of any of your asthma medications. Decreases in corticosteroid doses should be performed under the direct supervision of a doctor.

Parasite infections: Cinqair (Reslizumab) may weaken your resistance to parasite infections. If you are living in or travelling to a region where parasite infections are frequent, discuss with your doctor any special precautions that may be needed.

Pregnancy: No studies have been done to determine the safety and effectiveness of Cinqair (Reslizumab) when used by women who are pregnant. This medication should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking Cinqair (Reslizumab), contact your doctor immediately.

Breast-feeding: It is not known if Cinqair (Reslizumab) passes into breast milk. If you are a breast-feeding mother and are taking Cinqair (Reslizumab), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.

Children: The safety and effectiveness of using this medication have not been established for children.